SEPTEMBER 17-18, 2025, NEWARK, NJ
Agenda
Displaying agenda in the event’s time zone (EDT, UTC -4)
Registration and Networking Breakfast
Sense Making with AI in the Data Age
This Masterclass on Sense Making with AI offers a comprehensive exploration into leveraging artificial intelligence (AI) tools and methodologies to extract valuable insights, make informed decisions, and navigate complexity with clarity.
Developed by industry experts and thought leaders at the forefront of AI innovation, this Masterclass delves into the intersection of human cognition and machine intelligence. Participants will embark on a journey to understand how AI technologies can augment human capabilities in sense making, enabling them to unravel intricate patterns, detect trends, and glean actionable intelligence from data-rich environments.
Presented by Atacana Group
Refreshment Break
Synthesizing Primary Research Into Actionable Insights and Presentations
Presented by Molekule
Networking Lunch
Kit-ing and Kiq-ing: Key Intelligence Topics and Questions – Asking the Right Questions Will Provide Critical Insight to Your Business
Presented by Lifescience Dynamics
Refreshment Break
Developing a Competitive Activity Framework to enhance organizational competitiveness
This workshop session, will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS' in-house proprietary methodologies.
Key to this session will be addressing business needs across the lifecycle, whereby participants will:
• Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
• Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
Receive hands-on opportunities to apply learnings to a pharma case study in a learning environment
• Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.
Presented by INOVIS
Refreshment Break
Learn how to ‘GameStorm’ and become familiar with the giants of competitive analysis models and frameworks
• VUCA –focusing specifically on the concept of the competitive “Why?”
• Scenario Planning
• Porters Five Forces Explained
• Porters Four Corners Explained
• Blindspot Analytical Framework
Presented by Dig Worldwide
Masterclasses Conclude
Registration & Networking Breakfast in Exhibition Hall
Chairperson’s Opening Remarks
Presented by Johnson & Johnson
Keynote: Years of the Inflation Reduction Act: What Have We Learned?
Presented by PhRMA
Keynote: Empowering Global and Market Affiliate CI Teams with Robust and Engaging Intelligence
Presented by Molekule Consulting
Networking & Refreshments in Exhibition Hall
Keynote: China and emerging markets as growing players in Pharma
Presented by Lifescience Dynamics and Pfizer
Keynote: Executive Level Boardroom Discussions
Presented by Abbott, AbbVie, BioMarin, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Johnson & Johnson, and Novartis Institutes for BioMedical Research
“Ask the Experts” Interactive Round Tables
ROUNDTABLE 1
Creating a Cross-brand / Therapeutic Area CI Approach
Presented by Ferring
ROUNDTABLE 2
Unlocking the Market Opportunity – The Power of CI
Presented by Astellas
ROUNDTABLE 3
Leveraging CI Input & Analysis to Support Key Investment Decisions Across the Portfolio
Presented by Ipsen
ROUNDTABLE 4
What Would you Tell Your Younger CI Self? Learnings from the Journey
Presented by Abbott
ROUNDTABLE 5
Delivering on KITs/KIQs vs. Objectives vs. Valued Contributions
Presented by MorphoSys
ROUNDTABLE 6
AI Powered CI: Now a Reality
Experience speed and efficiency of an AI powered command center that generates real-time Insights, reduces costs, and democratizes information across enterprise functions.
Presented by PharmaEdge
Networking Luncheon
TRACK A
Is My AI Better than your AI?
There is no match for human curiosity and our ability to frame a key intelligence question (KIQ) that has the potential to allow one competitor to gain an edge over another.
Dig Worldwide’s talk will delve into why human intelligence will always persist as an essential component in the pursuit of competitive advantage. Tony Nagle and Beth Elliott Co-Founders of Dig Worldwide will present a primary intelligence practitioners view on:
• How is AI changing competitive intelligence?
• Why Human Intelligence will always be irreplaceable by AI?
• Their thoughts on a “Golden Mean”
Presented by Dig Worldwide
TRACK B
Slicing Through the Complexity of Solid Tumor Trials with SLICER: Innovative Approaches in Trial Analysis
CT.gov language for solid tumor trials is often ambiguous and non-standardized, turning landscaping efforts into a nightmare of trial record interpretation and manual annotation. By examining various approaches, including studying the accuracy of advanced NLP technologies, we reimagine how to efficiently conduct pan-tumor and detailed trend analyses in solid tumor trials. Don’t miss this session if your CI and strategy teams need augmented data sets beyond the unstructured nature of clinical trial records.
Presented by Fenix Group International
TRACK C
The State of the Biopharmaceutical Industry
As the biopharmaceutical industry is resiliently recovering from the challenges presented by the pandemic, the recovery has been already overshadowed by a range of macroeconomic and geopolitical factors.
The issues with supply-demand imbalance, inflation, market volatility and geopolitical tensions & conflicts continue to pose a degree of instability and challenges for economic recovery and growth prospects. Although the pharmaceutical industry is often viewed as recession-proof, it is not immune to future challenges. Ongoing drug pricing and reimbursement constraints, regulatory challenges, pressures to innovate, increased competition, as well as biotech funding instability will continue to test the biopharmaceutical industry in the coming years. In The State of the Biopharmaceutical Industry discussion, GlobalData will highlight what we see are the factors impacting business environment and key trends that are going to shape the biopharmaceutical industry in 2025 and beyond.
Presented by GlobalData Healthcare
TRACK A
Leveraging Intelligence to Inform Innovation Strategy
Research and analysis are the fundamental building blocks behind any innovation. They're essential for discovering unmet needs, learning what is or isn't already in the marketplace, gaining input on how to differentiate, and assessing the feasibility of a successful market entrance with an innovative product or service.
This session will share practical examples of how CI researchers/analysts help solve innovation team challenges around deciding where to invest and divest. and outline the key action steps to building a mutually beneficial relationship with Innovation teams to formulate effective Innovation strategies.
Objectives:
• Learn how research functions can best collaborate with an Innovation team
• Understand the kinds of insight most helpful for Innovation Labs
• Gain input on the integration of market, customer, and competitive research
• Acquire tips on how to foster engaging conversations that drive action to create strategies
• Apply best practices to support Innovation
Presented by Proactive Worldwide
TRACK B
Optimizing the Strategic Value of Cross-Functional Competitive Intelligence
CI leaders are charged with supporting stakeholders across all functions and across assets from early-to-late stage. This breadth of oversight often stretches CI leader capacity and can unintentionally promote transactional arrangements with internal stakeholders. Today, we’ll discuss how to strengthen cross-functional CI workflows and relationships, improve research efficiency and optimize methodology, all towards the goal of strengthening the strategic value of the CI.
Presented by Norstella
TRACK C
CI for Nontraditional Client Archetypes
In pharma, brand and marketing are perceived as the typical consumers who commission and fund CI. But CI is essential for many other functions, including medical, commercial development, and BD&L. We’ll discuss unique ways of working and best practices for delivering high impact CI to these non-traditional archetypes.
Presented by Deallus
TRACK A
AI-Enabled Continuous Monitoring: Enhancing Accuracy, Speed, and Strategic Insights
Discover how AI is revolutionizing the Continuous Monitoring process, by providing efficiencies through automation, exponential scale through rapid data processing, and surfacing insights for better decision making.
Presented by DataZymes
TRACK B
How Pharmas Use Generative AI for Competitive Intelligence Research
Pharmaceutical companies are some of the world's most technologically sophisticated enterprises, so it's not surprising they're at the vanguard of using generative AI. One early application is for mining market and competitive intelligence research. In this session, learn how leading drug development companies are employing GenAI to instantly derive insights from vetted credible sources to inform their product development, strategy and marketing decisions.
Presented by Northern Light
TRACK C
Life Sciences CI Survey: Insights from Sedulo Group
Learn how your peers navigate the constantly changing CI landscape and gain valuable benchmarks and insights to enhance your CI strategies. You’ll see data gathered from 109 survey responses across 90 life sciences companies.
This comprehensive survey analyzes competitive intelligence (CI) practices, challenges, and trends within the life sciences sector.
Session Highlights:
• Explore CI Practices and Trends
• Benchmarking CI Structures and Approaches
• Understand Peer Challenges and Solutions
• Discover Vendor Vetting and Engagement Strategies
• Uncover Future Perspectives on Life Sciences CI
Presented by Sedulo Group
Networking & Refreshments in Exhibition Hall
TRACK A
The Evolution of CI Beyond the Brand
• Typical CI methodologies and planning window• The forces at work in the healthcare marketplace (2030+)
• How to project the future marketplace of 2030+ with increased confidence
Presented by Ionis
TRACK B
Commercial vs Medical Insights: Bridging the Gap
Presented by Legend Biotech
TRACK C
Bending Without Breaking: Maintaining CI Excellence in a Season of Shrinking Budgets
When times are tough and budgets are tight, how do you flex and adapt to continue meeting stakeholder needs? Through a series of case studies and anecdotes, we’ll have a discussion on best practices for doing great work without stressing (too much) over funding.
Presented by Bristol Myers Squibb
TRACK A
You 2.0: Ferma as Your Force Multiplier
With Ferma, you’ll have human-centric AI to blast ahead of your competitors. No more being overwhelmed by raw data. Instead, you'll have the power to make data-driven decisions with ease.
Presented by Ferma
TRACK B
CI for Strategic Business Decisions by Leveraging the Power of AI
Competitive Intelligence is imperative for any strategic business decision making. In today's era, there is no dearth of information, the critical part is to arrive at the right decisions in the least amount of time.
Our AI-enabled technology facilitates reduction of noise to quickly arrive at clear and structured outcomes. In our discussion of the case study, we will talk about how CI goes beyond answering your present KBQs to creating a path for you to explore future opportunities thus enabling you to make the next best move. In our session we will elaborate on –
• How to identify the future market opportunities for any asset
• How to maximize the scope of the asset beyond its target indication
• How to shortlist the most suitable and commercially viable option for your business
Presented by PharmaACE
TRACK C
Case Studies: AI in Action - Driving ROI in Life Sciences Development
In recent years, Life Sciences have leapfrogged other industries in AI integration, revolutionizing research, clinical trials, regulatory processes, and Competitive Intelligence (CI).
What was once just a topic of discussion is now a powerful reality, delivering rapid ROI across the development pipeline.
This session will showcase compelling case studies highlighting successful AI implementations within Tier 1 Pharma organizations. Discover how AI is not just a buzzword anymore, but a transformative force enabling organizations to streamline workflows, enhance decision-making, and maintain a competitive edge.
You’ll also learn how GlobalReach BI has integrated OpenAI into its SPRING platform, making competitive intelligence faster, more accurate, and more insightful than ever before. The combination of streamlined workflows and personalized insights from secondary and primary intelligence, powered by AI, is setting new standards in the industry.
Don’t miss this opportunity to explore the tangible benefits of AI in Large Pharma. Secure your spot now for the upcoming PharmaCI conference and be part of the conversation shaping the future of Life Sciences.
Presented by GlobalReach BI
TRACK A
How to antiCIpate competitive moves and deliver intelligence that aCtIvates
Presented by AbbVie, Intuitive, Precision and Takeda Pharmaceuticals
TRACK B
Increasing & Maximizing the Predictive Value of CI
Presented by Bristol Myers Squibb, CorMedix, Regeneron Pharmaceuticals, and Takeda Pharmaceuticals
TRACK C
Knowledge Management and Decision Making in Pharma and Biotech
Presented by AbbVie, inThought Labs and Johnson & Johnson
Cocktail Reception & Networking
Registration & Networking Breakfast in Exhibition Hall
TRACK A
Visit the Exhibition Hall
TRACK B
How to be an Influencer of Strategic Decisions
Presented by AbbVie, Dewpoint Therapeutics, Eisai, Merck, and Sanofi
TRACK C
Elevating CI Partnership With Cross-Functional Team: Experts From Marketing and Medical
Presented by AbbVie and Vertex
TRACK A
Building an Effective Partnership Between CI Providers and Pharma - Case Study on Competitive Simulation Workshops
Competitive simulation workshops are a powerful and diverse tool at the disposal of any CI function. In this presentation we will outline the basic elements that are key to any successful CI workshop. Using examples from our experiences at Servier, and in collaboration with our vendors Lifescience Dynamics, we will describe some recent successes we’ve had in conducting CI workshops with minimal notice but maximum impact and value.
Presented by Lifescience Dynamics and Servier
TRACK B
Transforming Market Insights in Pharma with AI-Driven Analysis
Utilizing AI-powered analysis of clinical data to uncover crucial market trends and opportunities in the pharmaceutical industry.
Presented by LARVOL
TRACK C
CI’s New Parameters: Mapping the Impact of Emerging Hot Topics
Adding new parameters to CI programs can help with differentiation and benchmarking…or they can simply create noise.
Join Trinity Life Sciences as we sort through globally hot topics such as AIML, DEI and environmental impact to answer the questions:
What hot topic is the competition focused on?
Why should you include these as part of your long-term strategy?
Where can you differentiate?
Which of these topics can be dismissed for now?
Presented by Trinity Life Sciences
Networking & Refreshments in Exhibition Hall
TRACK A
Are Disruptors Disrupting Your Strategy?
With the pace of innovations coming online, disruptors are fundamentally evolving and altering the competitive landscape and our ways of working. As the rate of change increases, pharma and healthcare companies must identify and deploy resilient strategies that not only withstand but, more importantly, capitalize on emerging opportunities. Join us as we examine some of the most poignant disruptors. We will also explore the tools and methods CI/MI practitioners use to better predict, adjust, and even enhance strategies to stay competitive.
Presented by Fletcher
TRACK B
Endpoints & Outcomes: Your New Favorite Arrows Are in Your CI Quiver
Join us to explore how competitive intelligence teams leverage Kognitic’s newest platform feature to simplify trial result analysis, remap overgrown pipelines, and enhance oncology efficacy benchmarking. Discover how early users benefit from this next-gen tool, centralizing outcomes data and driving better decision-making. Limited early access is available – don’t miss the launch!
Presented by Kognitic
TRACK C
Optimal Integration of Data, Tech and Subject Matter Expertise: Empowering You to Develop a Sustainable Competitive Advantage
Differentiation, order of entry and the speed to market significantly impact the market share that our clients can stake claim to. To ensure that our clients are ahead of the curve and have a sustained competitive advantage we help them be better and faster at understanding the competitor clinical scenarios allowing our clients to remain informed and helping them make decisions proactively. Our ‘Prescient’ approach to clinical data analytics brings you an objective, evidence-based answer that combines the best of data automation, visualization and insight from our subject matter experts.
Presented by Prescient
“Ask the Experts” Interactive Round Tables
ROUNDTABLE 1
Creating a Cross-brand / Therapeutic Area CI Approach
Presented by Ferring
ROUNDTABLE 2
Unlocking the Market Opportunity – The Power of CI
Presented by Astellas
ROUNDTABLE 3
Leveraging CI Input & Analysis to Support Key Investment Decisions Across the Portfolio
Presented by Ipsen
ROUNDTABLE 4
What Would you Tell Your Younger CI Self? Learnings from the Journey
Presented by Abbott
ROUNDTABLE 5
Delivering on KITs/KIQs vs. Objectives vs. Valued Contributions
Presented by MorphoSys
Networking Luncheon
Announcement of Raffle Prize Winners
Generics & Biosimilars – Important Learnings from Real World Case Studies
This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically, this presentation will enable you to
1. Advance your understanding of core regulatory routes, timelines and strategies
2. Understand core Gx/biosimilar product development and entry strategies
3. Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches
Presented by INOVIS
Futureproof Your Commercial Strategy with AI and Human Expertise to Overcome Uncertainty
• Explore how the combination of AI augmentation and human expertise is revolutionizing agile, cross-functional decision-making
• Work with future-looking insights from real-time data streams to sidestep hidden pitfalls to ensure long-term success
Presented by Atacana Group
Beyond Boundaries: AI/ML Solutions for Bridging the Tech Divide
Presented by Fenix Group International
A Look Forward: Summary & Key Takeaways
Presented by Johnson & Johnson